Advertisement.

BNTX Projected Dividend Yield

ADS/BioNTech SE ( NASDAQ : BNTX )

BioNTech SE is a Germany-based clinical-stage biotechnology company. Co. focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. Co. is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific approaches and technology platforms, including individualized mRNA-based product candidates, chimeric antigen receptor T-cells, checkpoint immunomodulators, targeted cancer antibodies and small molecules.

12 YEAR PERFORMANCE RESULTS

BNTX Dividend History Detail
BNTX Dividend News
BNTX Competitors News

# of Shares: 0

Closing Price: 120.38

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2023	0.00	0%	0	$ 0.00	0.00%
2024	1.55	0%	0	$ 0.00	1.29%
2025	0.00	0%	0	$ 0.00	1.29%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 1.29%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
2022	N/A	Jun 02, 2022	Jun 03, 2022	Jun 17, 2022	1.5498
2022 Total:					1.5498